ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ASTH vs AMN // FORWARD P/E MULTIPLE

Astrana Health Inc. (NASDAQ) VS. AMN Healthcare Services Inc (NYSE) • 15-METRIC TALLY: ASTH 6 — AMN 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASTH VS. AMN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ASTH AMN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 28.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 4.60% -7.20% +11.80 ASTH /roic <GO>
EV/EBITDA & P/E Valuation 27.3x — — TIE /valuation <GO>
Free Cash Flow Yield 5.75% 12.86% -7.11 AMN /fcf-yield <GO>
Operating Margin 2.50% -2.00% +4.50 ASTH /operating-margins <GO>
Net Profit Margin 0.80% -3.50% +4.30 ASTH /net-margins <GO>
Revenue Growth (YoY) 56.40% -8.50% +64.90 ASTH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.43% 0.00% +0.43 ASTH /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.54 2.76 -0.22 AMN /balance-sheet <GO>
Piotroski F-Score Quality 6/9 5/9 +1.00 ASTH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.7 75.9 -29.19 AMN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE 63.6x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.82B $1.82B -$1.5M AMN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ASTH REV AMN REV ASTH GROSS % AMN GROSS % ASTH FCF AMN FCF
FY 2025 $3.18B $2.73B — 28.3% $104.5M $233.8M
FY 2024 $2.03B $2.98B — 30.8% $44.2M $239.5M
FY 2023 $1.39B $3.79B — — $68.2M $372.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASTH // BETA —
AMN // BETA —